Page last updated: 2024-09-04

6-hydroxynorketamine and 6-cyano-7-nitroquinoxaline-2,3-dione

6-hydroxynorketamine has been researched along with 6-cyano-7-nitroquinoxaline-2,3-dione in 1 studies

Compound Research Comparison

Studies
(6-hydroxynorketamine)
Trials
(6-hydroxynorketamine)
Recent Studies (post-2010)
(6-hydroxynorketamine)
Studies
(6-cyano-7-nitroquinoxaline-2,3-dione)
Trials
(6-cyano-7-nitroquinoxaline-2,3-dione)
Recent Studies (post-2010) (6-cyano-7-nitroquinoxaline-2,3-dione)
382362,6981353

Protein Interaction Comparison

ProteinTaxonomy6-hydroxynorketamine (IC50)6-cyano-7-nitroquinoxaline-2,3-dione (IC50)
Glutamate receptor 1Homo sapiens (human)1.02
Glutamate receptor 2Homo sapiens (human)1.02
Glutamate receptor 3Homo sapiens (human)1.02
Glutamate receptor 4Homo sapiens (human)1.02

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chou, D; Huang, Y; Ko, CY; Ye, L; Zheng, C; Zheng, Y1

Other Studies

1 other study(ies) available for 6-hydroxynorketamine and 6-cyano-7-nitroquinoxaline-2,3-dione

ArticleYear
Ketamine metabolite (2R,6R)-hydroxynorketamine enhances aggression via periaqueductal gray glutamatergic transmission.
    Neuropharmacology, 2019, Volume: 157

    Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Aggression; Animals; Behavior, Animal; Dose-Response Relationship, Drug; Excitatory Amino Acid Agents; Female; Ketamine; Male; Microinjections; Miniature Postsynaptic Potentials; Periaqueductal Gray; Rats; Synaptic Transmission

2019